Annual Drug Patent Expirations for REZUROCK Rezurock is a drug marketed by Kadmon Pharms Llc and is included in one NDA. There are four patents protecting this drug. This drug…
The post New patent for Kadmon Pharms drug REZUROCK appeared first on DrugP…
This chart shows the drugs with the most patents in South Korea. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical drugs have the most drug patents in South Korea?…
Which pharmaceutical drugs have the most drug patents in South Korea? Read Post »
Annual Drug Patent Expirations for VEKLURY Veklury is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are ten…
The post New patent for Gilead Sciences drug VEKLURY appeared first on DrugPatent…
Annual Drug Patent Expirations for CONTRAVE Contrave is a drug marketed by Nalpropion and is included in one NDA. It is available from three suppliers. There are nineteen patents protecting…
The post New patent for Nalpropion drug CONTRAVE appeared fir…
This chart shows the drugs with the most patents in Japan. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Japan? ap…
Which pharmaceutical drugs have the most drug patents in Japan? Read Post »
Annual Drug Patent Expirations for RYDAPT Rydapt is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent for Novartis drug RYDAPT appeared first on DrugPatent…
This chart shows the drugs with the most patents in China. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in China? ap…
Which pharmaceutical drugs have the most drug patents in China? Read Post »
Annual Drug Patent Expirations for VIBERZI Viberzi is a drug marketed by Allergan Holdings and is included in one NDA. It is available from one supplier. There are eighteen patents…
The post New patent for Allergan Holdings drug VIBERZI appeared first …
Annual Drug Patent Expirations for OZEMPIC Ozempic is a drug marketed by Novo and is included in one NDA. It is available from three suppliers. There are twenty-three patents protecting…
The post New patent for NOVO drug OZEMPIC appeared first on DrugP…
Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. There are twenty-three patents protecting…
The post New patent for NOVO drug SAXENDA appeared first on DrugPat…
Get new actionable insights and updates from BiotechBlog
